Click here for Canada website

Covis Pharma Reports on FDA Advisory Committee Hearing for Makena®

Oct 19, 2022

Press Release Covis Pharma Reports on FDA Advisory Committee Hearing for Makena® Zug, Switzerland, 19 October 2022 – Covis Pharma Group (the “Company”), today reported that the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee to the U.S. Food and Drug...

Covis Pharma Provides Update on FDA Public Hearing for Makena®

Jun 14, 2022

Press Release Covis Pharma Provides Update on FDA Public Hearing for Makena® Zug, Switzerland, June 14, 2022 – Covis Pharma GmbH, an affiliate of Group S.à r.l. (collectively, “Covis”), announced today that the U.S. Food & Drug Administration (FDA) anticipates...

Covis Pharma Group Announces Two Executive Management Team Appointments

Jan 31, 2022

Press Release Covis Pharma Group Announces Two Executive Management Team Appointments – Michelle Lock Joins Covis Pharma as Chief Operating Officer. – Also Announces Executive Leadership Transition with the Appointment of Sandy Loreaux as President, U.S. Business....
Skip to content